COMMUNIQUÉS West-GlobeNewswire

Longeveron® Lomecel-B™ Data in Alzheimer’s Disease Selected for Late Breaking Poster Presentation at the Clinical Trials on Alzheimer’s Disease Conference (CTAD24)

14/10/2024 - 15:05

MIAMI, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing regenerative medicines, today announced that its submission entitled “Lomecel-B inhibition of [...]

INVO Bioscience and NAYA Biosciences Close Merger, Combined Company to Operate as NAYA Biosciences (NASDAQ: NAYA)

14/10/2024 - 15:18

Combined company to expand portfolio of clinical & commercial-stage assets in fertility, oncology, and autoimmune diseases SARASOTA, Fla. and MIAMI, Oct. 14, 2024 (GLOBE NEWSWIRE) -- INVO Bioscience (“INVO”) (NASDAQ [...]

You’re Invited! WonderTree’s Innovative, Team-Based Clinic to Celebrate Grand Opening

14/10/2024 - 15:30

On Friday, October 18, WonderTree will be showcasing its model for child and adolescent mental healthcare WonderTree founders Dr. Stephanie Lavoie (left) and Dr. Michelle Fardella (right) ORANGEVILLE, Ontario, Oct. 14, [...]

Treace Files Patent Infringement and Unfair Competition Suit to Protect Lapiplasty® Bunion Technology

14/10/2024 - 15:45

PONTE VEDRA, Fla., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of [...]

Cookie Diet announces the launch of new Four-Week Program

14/10/2024 - 16:20

America's most convenient diet revealed: These famous weight-loss cookies make it easy to shred kilos AND there’s a money-back guarantee. SYDNEY, Australia, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Dr Siegal’s famous Cookie [...]

Biofrontera Inc. Announces Database Lock Of Phase 3 Study Of Ameluz®-Photodynamic Therapy (PDT) In The Treatment Of Superficial Basal Cell Carcinoma (sBCC)

14/10/2024 - 16:30

First Phase 3 PDT study in patients with sBCC in the United States. Rigorous dual endpoints requiring complete clinical and cytological clearance of malignant lesions. Data now being analyzed, interim results expected [...]

Psyence Group Enters into Debt-for-Equity Swap Agreement with its NASDAQ-Listed Associate, Psyence Biomedical

14/10/2024 - 16:43

TORONTO, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Psyence Group Inc (" Psyence Group " or the " Company ") (CSE: PSYG) hereby announces that it has entered into a debt-for-equity swap agreement (the " Debt Swap Agreement ") [...]

Ipsen reçoit un deuxième prix Shingo pour son excellence opérationnelle

14/10/2024 - 18:00

Ipsen est la première société pharmaceutique au monde à avoir reçu le prix Shingo pour deux sites de production de médicaments destinés aux patients. Ipsen a reçu son premier prix Shingo pour son site de production de [...]

Ipsen receives its second Shingo Prize for operational excellence

14/10/2024 - 18:00

Ipsen is the first pharma company in the world to receive Shingo Prizes for two sites producing treatments for patients Ipsen’s first Shingo Prize was received by its production site in Signes, France in 2020, followed [...]

Norton Healthcare acquires groundbreaking focused ultrasound technology

14/10/2024 - 19:26

Norton Neuroscience Institute first in Kentucky with incisionless surgery for essential tremor, tremor-dominant Parkinson’s disease LOUISVILLE, Ky., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Norton Neuroscience Institute is the [...]

Inventiva annonce la mise à disposition d'un prospectus dans le cadre de son financement par l’émission d’actions ordinaires et de bons de souscription d’action préfinancés

14/10/2024 - 19:45

Daix (France), Long Island City (New York, États-Unis), le 14 octobre 2024 – Inventiva (Euronext Paris et Nasdaq: IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement [...]

Inventiva announces the availability of a prospectus in connection with its financing through the issuance of ordinary shares and pre-funded warrants

14/10/2024 - 19:45

Daix (France), Long Island City (New York, United States), October 14, 2024 – Inventiva (Euronext Paris and Nasdaq: IVA) (“ Inventiva ” or the “ Company ”), a clinical-stage biopharmaceutical company focused on the [...]

The Association of American Physicians and Surgeons (AAPS) Sues to Block Expansion of the Federal Police State

14/10/2024 - 19:50

TUCSON, Ariz., Oct. 14, 2024 (GLOBE NEWSWIRE) -- The Association of American Physicians and Surgeons (“AAPS”) served a lawsuit on Oct 11, seeking to block the upcoming requirement that tens of millions Americans provide [...]

Single TearCare® Treatment Improved Functional Visual Outcomes as well as Signs and Symptoms of Patients with Dry Eye Disease in Investigator-Initiated Trial

14/10/2024 - 22:05

The study found improvements in reading speed, vision-related quality of life, and suggested potential benefits of an interventional approach for patients with dry eye disease MENLO PARK, Calif., Oct. 14, 2024 (GLOBE [...]

Spectral AI, Inc. Announces Return of Founder Dr. J. Michael DiMaio as Chairman of the Board of Directors

14/10/2024 - 22:05

DALLAS, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment [...]

HeartSciences to Participate in the 2024 Maxim Healthcare Virtual Summit

14/10/2024 - 22:15

Southlake, TX, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered medical technology [...]

The Joint Corp. Appoints Sanjiv Razdan President and Chief Executive Officer

14/10/2024 - 22:15

-Seasoned Franchise Executive to also Join the Company’s Board of Directors - SCOTTSDALE, Ariz., Oct. 14, 2024 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT) (“The Joint or “the Company”), the nation’s largest [...]

Information relative au nombre total des droits de vote et d’actions composant le capital social au 30 septembre 2024

14/10/2024 - 22:30

Information relative au nombre total des droits de vote et d’actions composant le capital social au 30 septembre 2024 (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) Place de cotation : NYSE [...]

Information regarding the total number of voting rights and total number of shares of the Company as of September 30, 2024

14/10/2024 - 22:30

Information regarding the total number of voting rights and total number of shares of the Company as of September 30, 2024 (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : [...]